The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Rituximab treatment of idiopathic membranous nephropathy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2825 · Cited by 2,755
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Maloney, D. G., Grillo-López, A. J., White, C. A., Bodkin, D., Schilder, R. J., Neidhart, J. A., Janakiraman, N., Foon, K. A., Liles, T.-M., Dallaire, B. K., et al. (1997) · Blood · doi:10.1182/blood.v90.6.2188 · Cited by 1,733
Looney, R. J., Anolik, J. H., Campbell, D., Felgar, R. E., Young, F., Arend, L. J., Sloand, J. A., Rosenblatt, J., & Sanz, I. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20430 · Cited by 776
Davis, T. A., Grillo-López, A. J., White, C. A., McLaughlin, P., Czuczman, M. S., Link, B. K., Maloney, D. G., Weaver, R. L., Rosenberg, J., & Levy, R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3135 · Cited by 687
Keane, W. F., Brenner, B. M., de Zeeuw, D., Grunfeld, J.-P., McGill, J., Mitch, W. E., Ribeiro, A. B., Shahinfar, S., Simpson, R. L., Snapinn, S. M., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00885.x · Cited by 539
Anolik, J. H., Campbell, D., Felgar, R. E., Young, F., Sanz, I., Rosenblatt, J., & Looney, R. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10764 · Cited by 429
Ponticelli, C., Zucchelli, P., Passerini, P., Cesana, B., Locatelli, F., Pasquali, S., Sasdelli, M., Redaelli, B., Grassi, C., Pozzi, C., et al. (1995) · Kidney International · doi:10.1038/ki.1995.453 · Cited by 407
Rituximab for Refractory Wegener's Granulomatosis: Report of a Prospective, Open-Label Pilot Trial
Keogh, K. A., Ytterberg, S. R., Fervenza, F. C., Carlson, K. A., Schroeder, D. R., & Specks, U. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200507-1144oc · Cited by 399
Self-citationPiro, L. D., White, C. A., Grillo-López, A. J., Janakiraman, N., Saven, A., Beck, T. M., Varns, C., Shuey, S., Czuczman, M., Lynch, J. W., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008389119525 · Cited by 368
Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial
Cattran, D. C., Appel, G. B., Hebert, L. A., Hunsicker, L. G., Pohl, M. A., Hoy, W. E., Maxwell, D. R., Kunis, C. L., & Syndrome, F. T. N. A. N. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041484.x · Cited by 367
Self-citationClinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion
Leandro, M. J., Edwards, J. C. W., & Cambridge, G. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.10.883 · Cited by 345
Suppression of human B lymphocyte function by cyclophosphamide.
Cupps, T. R., Edgar, L. C., & Fauci, A. S. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.6.2453 · Cited by 183
Kerjaschki, D., & Neale, T. J. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122518 · Cited by 152
Apperloo, A. J., de Zeeuw, D., & de Jong, P. E. (1994) · PubMed · Cited by 138
Drug Insight: rituximab in renal disease and transplantation
Salama, A. D., & Pusey, C. D. (2006) · Nature Reviews Nephrology · doi:10.1038/ncpneph0133 · Cited by 129
Rituximab for Idiopathic Membranous Nephropathy
Ruggenenti, P. L., Chiurchiu, C. R., Abbate, M., Perna, A., Cravedi, P., Bontempelli, M., & Remuzzi, G. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01080905 · Cited by 97
Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
Rossing, P. R., Hommel, E. E., Smidt, U. M., & Parving, H. ‐. (1994) · PubMed · Cited by 93
Idiopathic membranous glomerulonephritis.
Cattran, D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051983.x · Cited by 78
Self-citationGonzalez‐Stawinski, G. V., Yu, P. B., Love, S. D., Parker, W., & Davis, R. D. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4980 · Cited by 72
Membranous nephropathy: Quo vadis?
Cattran, D. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00125.x · Cited by 36
Self-citationAnti-CD20 Therapy and Autoimmune Disease: Therapeutic opportunities and evolving insights
Silverman, G. J. (2006) · Frontiers in bioscience · doi:10.2741/2222 · Cited by 25
Cited by
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function
Pescovitz, M. D., Greenbaum, C. J., Krause-Steinrauf, H., Becker, D. J., Gitelman, S. E., Goland, R., Gottlieb, P. A., Marks, J. B., McGee, P. F., Moran, A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904452 · Cited by 1,093
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
Beck, L. H., Fervenza, F. C., Beck, D. M., Bonegio, R. G. B., Malik, F. A., Erickson, S. B., Cosio, F. G., Cattran, D. C., & Salant, D. J. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111125 · Cited by 471
Self-citationRituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
Dahan, K., Debiec, H., Plaisier, E., Cachanado, M., Rousseau, A., Wakselman, L., Michel, P.-A., Mihout, F., Dussol, B., Matignon, M., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040449 · Cited by 439
Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study
Fervenza, F. C., Abraham, R. S., Erickson, S. B., Irazabal, M. V., Eirin, A., Specks, U., Nachman, P. H., Bergstralh, E. J., Leung, N., Cosio, F. G., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05080610 · Cited by 299
Self-citation
Metadata
- Authors
- Fervenza, F. C., Cosio, F. G., Erickson, S. B., Specks, U., Herzenberg, A. M., Dillon, J. J., Leung, N., Cohen, I. M., Wochos, D. N., Bergstralh, E., Hladunewich, M., & Cattran, D. C.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 73
- Issue
- 1
- Pages
- 117-125
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2018459774
- Cited by
- 265
- References
- 22
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.